Those making a living off harvesting the potent venom of the Sonoran desert toad are getting caught in the crossfire of narco traffickers.
Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing...
Neuroscience research shows that the brain changes slowly through effortful learning, but can also rapidly rewire during transformative experiences, like...
A Canadian Senate committee is calling on the federal government to launch a “large-scale research program” to explore the therapeutic potential of...
The National Institutes of Health (NIH) is soliciting proposals to develop psychedelics into treatments for substance use disorder (SUD), with plans to...
Dana Larsen owns three shops in Vancouver that openly sell psychedelics like psilocybin mushrooms, DMT and peyote The post Vancouver police raid Medicinal...
–Company to host conference call to discuss positive Phase 2 CYB003 interim results today, November 1, 2023 at 11:00 a.m. ET – – Complete Phase 2...
This morning we received interim results on Cybin’s Phase 2 trial using its CYB003 psilocybin compound for depression. And they did not disappoint. The...
A Massachusetts campaign believes it has collected enough valid signatures to force lawmakers to consider a psychedelics legalization initiative—the...
As the psychedelic movement transforms and develops into a new entity, there is bound to be internal conflict and opposition. The fight to include indigenous...